Rocket Pharmaceuticals (RCKT) Times Interest Earned (2014 - 2026)
Rocket Pharmaceuticals' (RCKT) quarterly Times Interest Earned came in at -$102.56 in Q1 2026, up 24.82% year-on-year from -$82.17 in Q1 2025, and down 10.35% quarter-over-quarter from -$92.95 in Q4 2025.
Rocket Pharmaceuticals (RCKT) Times Interest Earned (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals has disclosed Times Interest Earned across 12 years of filings, most recently posting -$102.56 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$102.56, up 24.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$114.1 (up 20.32% YoY), and the FY2025 annual result was -$122.55, up 15.4% from the prior year.
- Times Interest Earned came in at -$102.56 for Q1 2026 at Rocket Pharmaceuticals, down from -$92.95 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$91.73 in Q1 2022 to a low of -$156.5 in Q2 2024.
- The 5-year median for Times Interest Earned is -$134.64 (2023), against an average of -$129.9.
- Across the five-year window, Times Interest Earned sank 304.38% in 2022 and advanced 29.88% in 2025, its largest moves.
- Rocket Pharmaceuticals' Times Interest Earned stood at -$147.93 in 2022, then climbed by 8.98% to -$134.64 in 2023, then gained by 1.55% to -$132.55 in 2024, then rose by 29.88% to -$92.95 in 2025, then dropped by 10.35% to -$102.56 in 2026.
- The last three Times Interest Earned figures came in at -$102.56 (Q1 2026), -$92.95 (Q4 2025), and -$110.46 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -258.33 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 11.79 |
| 10 | Rocket Pharmaceuticals | 296.03 Mn | 296.03 Mn | - | -102.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.56 |
| Dec 31, 2025 | -92.95 |
| Sep 30, 2025 | -110.46 |
| Jun 30, 2025 | -150.42 |
| Mar 31, 2025 | -136.42 |
| Dec 31, 2024 | -132.55 |
| Sep 30, 2024 | -147.40 |
| Jun 30, 2024 | -156.50 |
| Mar 31, 2024 | -143.05 |
| Dec 31, 2023 | -134.64 |
| Sep 30, 2023 | -139.51 |
| Jun 30, 2023 | -146.92 |
| Mar 31, 2023 | -132.89 |
| Dec 31, 2022 | -147.93 |
| Sep 30, 2022 | -125.78 |
| Jun 30, 2022 | -116.58 |
| Mar 31, 2022 | -91.73 |
| Dec 31, 2021 | -95.75 |
| Sep 30, 2021 | -92.97 |
| Jun 30, 2021 | -135.65 |